The ROE (Return on Equity) of Hansa Biopharma AB (HNSA.ST) is 629.06%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2025-12-31 | 629.06% |
| 2024-12-31 | 136.86% |
| 2023-12-31 | 495.44% |
| 2022-12-31 | -101.36% |
| 2021-12-31 | -72.37% |
| 2020-12-31 | -33.88% |
| 2019-12-31 | -63.97% |
| 2018-12-31 | -28.84% |
| 2017-12-31 | -28.01% |
| 2016-12-31 | -39.17% |